Clinuvel Pharmaceuticals | CUV - Sales Revenues

Stock Price
10.52
Daily Change
-0.53 -4.76%
Monthly
-10.13%
Yearly
-8.49%
Q1 Forecast
11.42

Clinuvel Pharmaceuticals reported AUD55.92M in Sales Revenues for its fiscal semester ending in June of 2024.





Sales Change Date
Avita Medical AUD 18.42M 14K Jun/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Mesoblast USD 13.2M 10.04M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025